Dr Lal Pathlabs announces acquisition of bal 30% stake in Centrapath Labs
Mumbai, Oct. 13 -- Dr Lal Pathlabs announced that its wholly owned subsidiary, PathLabs Unifiers (PUPL) has acquired balance 30% stake in Centrapath Labs (CPL), a subsidiary of PUPL, on 13 October 2026.
Pursuant to the aforesaid acquisition, CPL has become a Wholly Owned Subsidiary of PUPL.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.